Exabis Library
Welcome to the e-CCO Library!
P368: Vedolizumab in inflammatory bowel disease: a retrospective single-centre study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P369 Mycobacterium tuberculosis infection among patients with inflammatory bowel disease under biologics: experience of Croatian Tertiary Centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P369: Do teenager and adult onset Crohn´s disease patients have different outcomes? A Portuguese cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P369: Dual Biologic in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P369: Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P369: High prevalence of abdominal pain in Crohn's Disease patients of the TRUST study cohort- Is there a connection to inflammatory activity?
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P369: Improvement in patient-reported outcomes in 2 Phase 3 studies of tofacitinib in patients with moderately to severely active ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P369: Safety and lymphocyte-lowering properties of etrasimod (APD334), an oral, potent, next-generation, selective S1P receptor modulator, after dose escalation in healthy volunteers
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P369: The comparative frequency of clostridial infection in patients with ulcerative colitis receiving mesenchymal stromal cells and anti-cytokine therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P370 Endoscopic balloon dilatation in paediatric stricturing Crohn’s disease: A retrospective collaborative study of the paediatric IBD Porto group of ESPGHAN
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P370: A randomised controlled trial of acceptance and commitment therapy for the treatment of stress in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P370: Concomitant azathioprine prevents new-onset arthralgia after initiation of vedolizumab: A retrospective cohort study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P370: Correlation of the IBD Disk with intestinal ultrasound in patients with inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P370: Endosponge-assisted early surgical closure of ileal pouch-anal anastomotic leakage improves long-term outcomes
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P370: Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from 52-week phase 3 study U ACHIEVE maintenance
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P370: Quality of life of patients with inflammatory bowel diseases in remission on different forms of treatment
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P370: Treatment patterns in a managed care project with inflammatory bowel disease patients in Germany: CEDnetz study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P371 Self-medication with analgesics in ulcerative colitis: Results of a patient survey
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P371: Assessment Of Postoperative Complications Following Ileocecal Resection In Crohn's Disease From A Low-To-Middle Income Country
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P371: Concentrations of 6-thioguanine nucleotide correlate with both infliximab and adalimumab levels in patients with inflammatory bowel disease on combination therapy
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM